← Leaderboards
Julie M Liang
Opera Bioscience, Inc.
$1,523,994
Attributed
$1,523,994
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NSF$1,523,994 · 2
By mechanism
—$1,523,994 · 2
Top collaborators
No co-investigators on record.
Grant awards (2)
SBIR Phase II: A Gram-Negative Bacterial Secretion Platform for Cost-Effective, High-Purity Recombinant Protein Production$1,248,994
· FY2025 · TIP · contact PI
SBIR Phase I: A low-cost, bacterial production platform for the manufacturing of high purity recombinant proteins and growth factors$275,000
· FY2023 · TIP · contact PI